Polymethylene tetraamines as muscarinic receptor probes
- PMID: 2694524
Polymethylene tetraamines as muscarinic receptor probes
Abstract
The possibility that polymethylene tetraamines act as divalent ligands has been explored. Structure-activity relationship studies among polymethylene tetraamines have shown that four nitrogens are necessary for high affinity binding to M2 receptors while being less important for M3 muscarinic receptors. Replacement of one terminal methoxybenzyl group of the potent and selective muscarinic antagonist methoctramine by different moieties led to weaker antagonists suggesting that the two terminal nitrogens of methoctramine interact with two similar receptor sites. Data are presented which suggest that methoctramine might interact with four acidic residues of the receptor: two residues are buried in the third transmembrane segment whereas the others are located extracellularly on the loop 4-5 which may represent the allosteric site where several antagonists such as gallamine bind. An hypothetical model describing the interaction of methoctramine with the M2 receptor is proposed. It may provide a useful working hypothesis for the design of new selective muscarinic ligands.
Similar articles
-
Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.J Med Chem. 1998 Oct 8;41(21):4150-60. doi: 10.1021/jm981038d. J Med Chem. 1998. PMID: 9767650
-
Structure-activity relationships among methoctramine-related polymethylene tetraamines. 3. Effect of the four nitrogens on M2 muscarinic blocking activity as revealed by symmetrical and unsymmetrical polyamines.Farmaco. 1991 Mar;46(3):417-34. Farmaco. 1991. PMID: 1892500
-
Polymethylene tetraamine backbone as template for the development of biologically active polyamines.Med Res Rev. 2003 Mar;23(2):200-33. doi: 10.1002/med.10029. Med Res Rev. 2003. PMID: 12500289 Review.
-
Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.Mol Pharmacol. 1986 Jul;30(1):58-68. Mol Pharmacol. 1986. PMID: 3755217
-
The modes of binding of ligands to cardiac muscarinic receptors.Trends Pharmacol Sci. 1989 Dec;Suppl:31-4. Trends Pharmacol Sci. 1989. PMID: 2694519 Review.
Cited by
-
Allosteric drugs acting at muscarinic acetylcholine receptors.Neurochem Res. 2003 Apr;28(3-4):419-22. doi: 10.1023/a:1022888332221. Neurochem Res. 2003. PMID: 12675125 Review.
-
Biased signalling and allosteric machines: new vistas and challenges for drug discovery.Br J Pharmacol. 2012 Mar;165(6):1659-1669. doi: 10.1111/j.1476-5381.2011.01749.x. Br J Pharmacol. 2012. PMID: 22023017 Free PMC article. Review.
-
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.Pharmacol Rev. 2010 Jun;62(2):265-304. doi: 10.1124/pr.108.000992. Epub 2010 Apr 14. Pharmacol Rev. 2010. PMID: 20392808 Free PMC article. Review.
-
Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.Naunyn Schmiedebergs Arch Pharmacol. 2006 Jan;372(4):267-76. doi: 10.1007/s00210-005-0023-4. Epub 2005 Dec 16. Naunyn Schmiedebergs Arch Pharmacol. 2006. PMID: 16362429
-
Exploring the activity of polyamine analogues on polyamine and spermine oxidase: methoctramine, a potent and selective inhibitor of polyamine oxidase.J Enzyme Inhib Med Chem. 2019 Dec;34(1):740-752. doi: 10.1080/14756366.2019.1584620. J Enzyme Inhib Med Chem. 2019. PMID: 30829081 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources